ANSLY
Price
$88.57
Change
+$9.57 (+12.11%)
Updated
Sep 5 closing price
Capitalization
3.29B
PDEX
Price
$38.19
Change
-$7.55 (-16.51%)
Updated
Sep 5 closing price
Capitalization
124.57M
54 days until earnings call
Interact to see
Advertisement

ANSLY vs PDEX

Header iconANSLY vs PDEX Comparison
Open Charts ANSLY vs PDEXBanner chart's image
Ansell
Price$88.57
Change+$9.57 (+12.11%)
Volume$200
Capitalization3.29B
Pro-Dex
Price$38.19
Change-$7.55 (-16.51%)
Volume$90.75K
Capitalization124.57M
ANSLY vs PDEX Comparison Chart in %
Loading...
ANSLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDEX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANSLY vs. PDEX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANSLY is a Buy and PDEX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ANSLY: $88.57 vs. PDEX: $38.19)
Brand notoriety: ANSLY and PDEX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANSLY: 157% vs. PDEX: 211%
Market capitalization -- ANSLY: $3.29B vs. PDEX: $124.57M
ANSLY [@Pharmaceuticals: Other] is valued at $3.29B. PDEX’s [@Pharmaceuticals: Other] market capitalization is $124.57M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANSLY’s FA Score shows that 1 FA rating(s) are green whilePDEX’s FA Score has 0 green FA rating(s).

  • ANSLY’s FA Score: 1 green, 4 red.
  • PDEX’s FA Score: 0 green, 5 red.
According to our system of comparison, PDEX is a better buy in the long-term than ANSLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANSLY’s TA Score shows that 5 TA indicator(s) are bullish while PDEX’s TA Score has 5 bullish TA indicator(s).

  • ANSLY’s TA Score: 5 bullish, 2 bearish.
  • PDEX’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, ANSLY is a better buy in the short-term than PDEX.

Price Growth

ANSLY (@Pharmaceuticals: Other) experienced а +13.73% price change this week, while PDEX (@Pharmaceuticals: Other) price change was -18.54% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

PDEX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANSLY($3.29B) has a higher market cap than PDEX($125M). ANSLY has higher P/E ratio than PDEX: ANSLY (31.86) vs PDEX (14.30). ANSLY YTD gains are higher at: 7.307 vs. PDEX (-18.310). ANSLY has higher annual earnings (EBITDA): 260M vs. PDEX (14.4M). ANSLY has more cash in the bank: 88.5M vs. PDEX (9.89M). PDEX has less debt than ANSLY: PDEX (19.1M) vs ANSLY (806M). ANSLY has higher revenues than PDEX: ANSLY (2B) vs PDEX (64.1M).
ANSLYPDEXANSLY / PDEX
Capitalization3.29B125M2,632%
EBITDA260M14.4M1,806%
Gain YTD7.307-18.310-40%
P/E Ratio31.8614.30223%
Revenue2B64.1M3,125%
Total Cash88.5M9.89M895%
Total Debt806M19.1M4,220%
FUNDAMENTALS RATINGS
ANSLY vs PDEX: Fundamental Ratings
ANSLY
PDEX
OUTLOOK RATING
1..100
4813
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
66
Overvalued
PROFIT vs RISK RATING
1..100
10065
SMR RATING
1..100
9134
PRICE GROWTH RATING
1..100
5843
P/E GROWTH RATING
1..100
4097
SEASONALITY SCORE
1..100
1350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANSLY's Valuation (19) in the null industry is somewhat better than the same rating for PDEX (66) in the Medical Or Nursing Services industry. This means that ANSLY’s stock grew somewhat faster than PDEX’s over the last 12 months.

PDEX's Profit vs Risk Rating (65) in the Medical Or Nursing Services industry is somewhat better than the same rating for ANSLY (100) in the null industry. This means that PDEX’s stock grew somewhat faster than ANSLY’s over the last 12 months.

PDEX's SMR Rating (34) in the Medical Or Nursing Services industry is somewhat better than the same rating for ANSLY (91) in the null industry. This means that PDEX’s stock grew somewhat faster than ANSLY’s over the last 12 months.

PDEX's Price Growth Rating (43) in the Medical Or Nursing Services industry is in the same range as ANSLY (58) in the null industry. This means that PDEX’s stock grew similarly to ANSLY’s over the last 12 months.

ANSLY's P/E Growth Rating (40) in the null industry is somewhat better than the same rating for PDEX (97) in the Medical Or Nursing Services industry. This means that ANSLY’s stock grew somewhat faster than PDEX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANSLYPDEX
RSI
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
40%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
37%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
39%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ANSLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDEX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AWLRF0.420.02
+3.75%
Awale Resources Limited
MDIKF18.29N/A
N/A
Modec Inc.
STEK0.01N/A
-3.45%
Stemtech Corp.
OLVI0.70-0.05
-6.67%
Oliveda International, Inc.
TNABY11.60-2.38
-17.02%
Tenaga Nasional Berhad

ANSLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANSLY has been loosely correlated with BRSYF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ANSLY jumps, then BRSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANSLY
1D Price
Change %
ANSLY100%
+13.73%
BRSYF - ANSLY
61%
Loosely correlated
N/A
IOBCF - ANSLY
43%
Loosely correlated
N/A
VERO - ANSLY
33%
Poorly correlated
N/A
FSPKF - ANSLY
26%
Poorly correlated
N/A
PDEX - ANSLY
22%
Poorly correlated
-16.51%
More

PDEX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDEX has been loosely correlated with LMAT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PDEX jumps, then LMAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
-16.51%
LMAT - PDEX
34%
Loosely correlated
+0.43%
LDXHF - PDEX
25%
Poorly correlated
-9.52%
TCMD - PDEX
24%
Poorly correlated
+0.30%
PRE - PDEX
23%
Poorly correlated
+1.00%
BDX - PDEX
23%
Poorly correlated
+0.59%
More